AI assistant
Sending…
LIFECORE BIOMEDICAL, INC. \DE\ — Director's Dealing 2012
Apr 4, 2012
33431_dirs_2012-04-04_79b4b6da-8826-4db7-ac03-4ec4179fe797.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LANDEC CORP \CA\ (LNDC)
CIK: 0001005286
Period of Report: 2012-04-02
Reporting Person: STEELE GARY T (Director, CEO and President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-04-02 | Common Stock | S | 14151 | $6.6373 | Disposed | 147508 | Indirect |
| 2012-04-03 | Common Stock | S | 6793 | $6.5646 | Disposed | 140715 | Indirect |
| 2012-04-04 | Common Stock | S | 9652 | $6.5586 | Disposed | 131063 | Indirect |
Footnotes
F1: All shares reported sold on this form 4 were sold pursuant to a 10b5-1 trading program.
More from LIFECORE BIOMEDICAL, INC. \DE\
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Director's Dealing
2026
Mar 3
Board/Management Information
2026
Jan 16
Investor Presentation
2025
Nov 17
Interim / Quarterly Report
2025
Nov 6
Earnings Release
2025
Nov 6
Declaration of Voting Results & Voting Rights Announcements
2025
Oct 31
Major Shareholding Notification
2025
Oct 17
Regulatory Filings
2025
Oct 1